IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity

1
ORAL PRESENTATION Open Access IL-15 deficient Tax mice reveal a role for IL-1a in tumor immunity Daniel A Rauch, John C Harding, Lee Ratner * From 16th International Conference on Human Retroviruses: HTLV and Related Viruses Montreal, Canada. 26-30 June 2013 IL-15 is recognized as a promising candidate for tumor immunotherapy and has been described as both a pro- moter of cancer and a promoter of anti-cancer immu- nity. IL-15 was discovered in cells transformed by HTLV-1, the etiologic agent of adult T cell leukemia / lymphoma (ATL) and the human retrovirus that carries the Tax oncogene. We have developed the TAX-LUC mouse model of ATL in which Tax expression drives both malignant transformation and luciferase expression, enabling non-invasive imaging of tumorigenesis in real time. To identify the role of IL-15 in spontaneous devel- opment of lymphoma in vivo, an IL-15-/- TAX-LUC strain was developed and examined. The absence of IL-15 resulted in aggressive tumor growth and acceler- ated mortality and demonstrated that IL-15 was not required for Tax-mediated lymphoma but was essential for anti-tumor immunity. Further analysis revealed a unique transcriptional profile in tumor cells that arise in the absence of IL-15 that included a significant increase in the expression of IL-1a and IL-1a-regulated cytokines. Moreover, anti-IL-1a antibodies and an IL-1 receptor antagonist (Anakinra) were used to interrogate the potential of IL-1a targeted therapies in this model. Taken together, these findings identify IL-15 and IL-1a as therapeutic targets in lymphoma. Published: 7 January 2014 doi:10.1186/1742-4690-11-S1-O11 Cite this article as: Rauch et al.: IL-15 deficient Tax mice reveal a role for IL-1a in tumor immunity. Retrovirology 2014 11(Suppl 1):O11. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit * Correspondence: [email protected] Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA Rauch et al. Retrovirology 2014, 11(Suppl 1):O11 http://www.retrovirology.com/content/11/S1/O11 © 2014 Rauch et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http:// creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Transcript of IL-15 deficient Tax mice reveal a role for IL-1α in tumor immunity

ORAL PRESENTATION Open Access

IL-15 deficient Tax mice reveal a role for IL-1a intumor immunityDaniel A Rauch, John C Harding, Lee Ratner*

From 16th International Conference on Human Retroviruses: HTLV and Related VirusesMontreal, Canada. 26-30 June 2013

IL-15 is recognized as a promising candidate for tumorimmunotherapy and has been described as both a pro-moter of cancer and a promoter of anti-cancer immu-nity. IL-15 was discovered in cells transformed byHTLV-1, the etiologic agent of adult T cell leukemia /lymphoma (ATL) and the human retrovirus that carriesthe Tax oncogene. We have developed the TAX-LUCmouse model of ATL in which Tax expression drivesboth malignant transformation and luciferase expression,enabling non-invasive imaging of tumorigenesis in realtime. To identify the role of IL-15 in spontaneous devel-opment of lymphoma in vivo, an IL-15-/- TAX-LUCstrain was developed and examined. The absence ofIL-15 resulted in aggressive tumor growth and acceler-ated mortality and demonstrated that IL-15 was notrequired for Tax-mediated lymphoma but was essentialfor anti-tumor immunity. Further analysis revealed aunique transcriptional profile in tumor cells that arise inthe absence of IL-15 that included a significant increasein the expression of IL-1a and IL-1a-regulated cytokines.Moreover, anti-IL-1a antibodies and an IL-1 receptorantagonist (Anakinra) were used to interrogate thepotential of IL-1a targeted therapies in this model.Taken together, these findings identify IL-15 and IL-1aas therapeutic targets in lymphoma.

Published: 7 January 2014

doi:10.1186/1742-4690-11-S1-O11Cite this article as: Rauch et al.: IL-15 deficient Tax mice reveal a rolefor IL-1a in tumor immunity. Retrovirology 2014 11(Suppl 1):O11.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submit

* Correspondence: [email protected] of Medicine, Washington University School of Medicine, St.Louis, Missouri, USA

Rauch et al. Retrovirology 2014, 11(Suppl 1):O11http://www.retrovirology.com/content/11/S1/O11

© 2014 Rauch et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative CommonsAttribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction inany medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.